Discrepancy between the European clinical guidelines and myocardial revascularization in patients with stable coronary artery disease in Russia

被引:1
|
作者
Kiselev, Anton R. [1 ]
Korotin, Alexey S. [1 ]
Posnenkova, Olga M. [1 ]
Popova, Yulia V. [1 ]
Prokhorov, Mikhail D. [2 ]
Gridnev, Vladimir I. [1 ]
机构
[1] Saratov State Med Univ, Dept New Cardiol Informat Technol, Res Inst Cardiol, 112 Bolshaya Kazachya Str, Saratov 410012, Russia
[2] Russian Acad Sci, Saratov Branch, Lab Nonlinear Dynam Modelling, Inst Radio Engn & Elect, Saratov 410019, Russia
关键词
coronary artery disease; myocardial revascularization; ESC; EACTS guidelines; clinical indications; OPTIMAL MEDICAL THERAPY; ISCHEMIC-HEART-DISEASE; BYPASS GRAFT-SURGERY; INTERVENTION; MANAGEMENT; LIFE; PCI;
D O I
10.1093/intqhc/mzy140
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines, six indications have been proposed for making a decision on myocardial revascularization in patients with stable coronary artery disease (CAD). Our aim was to study a discrepancy between the actual clinical situation and ESC/EACTS indications on performing the revascularization in patients with CAD in Russia. We used retrospective clinical data on patients with stable CAD enrolled in the 20122015 Russian Registry of Hypertension, Coronary Artery Disease, and Chronic Heart Failure. A total of 1522 patients with CAD (aged 53.0 8.5 years, 76.2% male) were used for analysis. All patients were divided into two groups: 591 patients with performed myocardial revascularization (named as R-CAD) and 931 patients refused from revascularization (named as NR-CAD). Factors associated with revascularization performance were identified by discriminant function analysis. ESC/EACTS indications for revascularization were assessed. A total of 1196 patients with CAD had any ESC/EACTS indication for revascularization, but only 40.2% of them had performed invasive coronary intervention. Myocardial revascularization was appropriate in 81.4% of R-CAD patients and 76.8% of NR-CAD patients. The main factor of revascularization performance was any stenosis > 50% and grades IIIIV of stable angina. With non-performed revascularization, the following factors were associated: limiting angina or angina equivalent, unresponsive to medical therapy, atherosclerotic peripheral arterial disease and increasing the New York Heart Association class of chronic heart failure. Most ESC/EACTS indications had little effect on decision-making on revascularization. There is a discrepancy between the actual clinical situation and ESC/EACTS guidelines on myocardial revascularization in patients with stable CAD in Russia.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [1] Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization
    Elbez, Yedid
    Cheong, Adrian P.
    Fassa, Amir-Ali
    Cohen, Eric
    Reid, Christopher M.
    Babarskiene, Ruta
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2016, 2 (01) : 23 - 32
  • [2] Appropriateness of coronary revascularization in patients with stable coronary artery disease:a multicenter clinical trial
    林深
    ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (04) : 208 - 208
  • [3] Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease
    Yates, Martin T.
    Soppa, Gopal K. R.
    Valencia, Oswaldo
    Jones, Sion
    Firoozi, Sami
    Jahangiri, Marjan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (02): : 606 - 610
  • [4] LIFE QUALITY ASSESSMENT OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE AFTER MYOCARDIAL REVASCULARIZATION
    Narkevich, I. A.
    Nemyatykh, O. D.
    Kovaleva, K. A.
    Ratova, L. G.
    Trushnikova, I. O.
    Parizhskaya, E. N.
    Konradi, A. O.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2020, 8 (06): : 465 - 475
  • [5] Revascularization strategies for patients with stable coronary artery disease
    Iqbal, J.
    Serruys, P. W.
    JOURNAL OF INTERNAL MEDICINE, 2014, 276 (04) : 336 - 351
  • [6] MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH DIFFUSE CORONARY ARTERY DISEASE
    Kurbanov, S.
    Akchurin, R.
    Shiryaev, A.
    Vasiliev, V.
    Galyautdinov, D.
    Vlasova, E.
    Ilina, L.
    Latypov, R.
    Mayorov, G.
    Zaykovskiy, V.
    Mukimov, S.
    ATHEROSCLEROSIS, 2019, 287 : E155 - E155
  • [7] Assessing the Association of Appropriateness of Coronary Revascularization and Clinical Outcomes for Patients With Stable Coronary Artery Disease
    Ko, Dennis T.
    Guo, Helen
    Wijeysundera, Harindra C.
    Natarajan, Madhu K.
    Nagpal, A. Dave
    Feindel, Christopher M.
    Kingsbury, Kori
    Cohen, Eric A.
    Tu, Jack V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (19) : 1876 - 1884
  • [8] Myocardial Revascularization in Chronic Stable Coronary Artery Disease - Pro CABG
    Pecha, S.
    Bernhardt, A.
    Reichenspurner, H.
    AKTUELLE KARDIOLOGIE, 2014, 3 (05) : 306 - 310
  • [9] Myocardial Revascularization in Chronic Stable Coronary Artery Disease Pro PCI
    Hamm, C. W.
    Liebetrau, C.
    AKTUELLE KARDIOLOGIE, 2014, 3 (05) : 302 - 305
  • [10] Revascularization in stable coronary artery disease
    Al-Lamee, Rasha K.
    Foley, Michael
    Rajkumar, Christopher A.
    Francis, Darrel P.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377